Quick Answer
AETHLON MEDICAL INC reported Cash and Equivalents of $5.50 million for fiscal year 2025.
AETHLON MEDICAL INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $5.50M | +1.1% |
| 2024 | $5.44M | -62.6% |
| 2023 | $14.53M | -14.9% |
| 2022 | $17.07M | +73.1% |
| 2021 | $9.86M | +2.7% |
| 2020 | $9.60M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $6.96M | +44.2% | +18.8% |
| September 30, 2025 | $5.85M | -14.7% | +55.5% |
| June 30, 2025 | $3.77M | -58.5% | -31.6% |
| March 31, 2025 | $5.50M | +1.1% | +14.0% |
| December 31, 2024 | $4.83M | -39.5% | -29.6% |
| September 30, 2024 | $6.86M | -32.6% | -24.4% |
| June 30, 2024 | $9.07M | -29.7% | +66.7% |
| March 31, 2024 | $5.44M | — | -31.7% |
- AETHLON MEDICAL INC showed an increase of +1.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, AETHLON MEDICAL INC’s cash and equivalents has declined by 42.7% (from $9.60 million to $5.50 million).
- The most recent figure is from AETHLON MEDICAL INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 26, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: